# Bioequivalence Study of Dapagliflozin 10 mg Film-coated Tablets

> **NCT06127212** · NA · COMPLETED · sponsor: **Dexa Medica Group** · enrollment: 24 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Dapagliflozin 10 mg film-coated tablet
- **DRUG:** Forxiga® 10 mg Film-Coated Tablet, manufactured by AstraZeneca Pharmaceuticals LP, USA for AstraZeneca Pharmaceuticals Co. Ltd., China imported by PT AstraZeneca Indonesia, Indonesia

## Key facts

- **NCT ID:** NCT06127212
- **Lead sponsor:** Dexa Medica Group
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-08
- **Primary completion:** 2023-03-15
- **Final completion:** 2023-05-06
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2023-11-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06127212

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06127212, "Bioequivalence Study of Dapagliflozin 10 mg Film-coated Tablets". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06127212. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*